Stock Evaluator: Carlsmed, Inc. (CARL)

Carlsmed, Inc. CARL

$17.22 -0.15 -0.86%
November 19, 2026 4:00:00 PM EST November 10, 2021 Volume: 95,447
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Commentary & Analysis


Financial Summary

Share Statistics CARL Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $471.9 $356.4 38%
Shares Out (Mil) 27.3 41.2 35%
Institutional Ownership 69.3% 83.1% 42%
Float (Mil) 15.7 36.7 25%
Beta na 0.89 na
Avg Daily Volume (000s) 235 318 47%
Price Change
(52-week)
40.6% 55.9% 83%
Growth CARL Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 11.8% na
Net Income (5yr) na (5.8%) na
EPS (5yr) na 10.6% na
Dividends (5yr) na 0.0% 0%
Cash Flow (5yr) na (15.6%) na
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 1 1 1
Current EPS ($0.410) ($1.510) ($1.560)
Month Ago EPS ($0.340) ($1.410) ($1.380)
# Rev Up 0 0 0
# Rev Down 1 1 1
Three Months Ago EPS ($0.340) ($1.410) ($1.380)
Year/Year Chg (8.5%) (28.9%) (45.9%)
Financials CARL Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $72 $123 23%
Net Income (TTM) (Mil) ($40) ($9) 18%
EPS (TTM) ($1.483) ($0.300) 17%
Operating Cash Flow (TTM) (Mil) ($34) ($1) 12%
Net Cash Flow (TTM) (Mil) ($79) $2 17%
Long-Term Debt (Q1) (Mil) $21 $21 33%
Enterprise Value (Q1) (Mil) $411 $381 33%
Valuation CARL Industry
Median
Percentile
(All Stocks)
P/B 6.24 2.46 86%
P/E na 25.5 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.3 na
Ratios CARL Industry
Median
Percentile
(All Stocks)
Gross Margin 77.0% 59.1% 87%
Net Margin (55.8%) (4.6%) 11%
ROA (32.0%) (9.9%) 16%
ROE (43.9%) (8.5%) 16%
Liabilities to Assets 34.4% 45.6% 25%
F-Score 2 4 7%

Carlsmed, Inc. did not pass any screens on 11/19/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors